Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Aortic Valve Insufficiency: early-phase trial registry

4 of 12 indexed Aortic Valve Insufficiency trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 4 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Aortic Valve Insufficiency: 12 US clinical trials tracked, 4 recruiting.

Aortic Valve Insufficiency is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is JenaValve Technology, running 3 of these trials.

Enrollment posture brief

Registry condition aortic-valve-insufficiency

OPEN 4 | RECR 33% | LATE 0 | EARLY 1 | RANK #1429 | SPON 3

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Aortic Valve Insufficien (th…33%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Aortic Valve Insufficiency

Aortic Valve Insufficiency lists 4 open slots (33% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Aortic Valve Insufficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Aortic Valve Insufficiency is recruiting below its size-band peers.

    4 of 12 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Aortic Valve Insufficiency research.

    JenaValve Technology accounts for 3 of 12 trials (25%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Aortic Valve Insufficiency enrolment sits around 532 participants.

    Median target enrolment is 532 among the 12 trials that report a genuine target (sentinel values excluded). 2 of those (16.7%) plan for fewer than 100 participants.

  4. Aortic Valve Insufficiency research is mostly interventional.

    9 interventional and 3 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

12 total, page 1 of 1

RECRUITING 10,000 participants

Transpacific TAVR Registry

Duk-Woo Park, MD

NCT03826264

RECRUITING NA 1,016 participants

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

JenaValve Technology

NCT06608823

RECRUITING NA 200 participants

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

Edwards Lifesciences

NCT05172973

RECRUITING NA 50 participants

The JenaValve ALIGN-AR LVAD Registry

JenaValve Technology

NCT06594705

ACTIVE NOT RECRUITING 1,000 participants

Identification of Genetic Causes of Calcific Aortic Valve Disease

Beth Israel Deaconess Medical Center

NCT04149600

ACTIVE NOT RECRUITING NA 777 participants

ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

Edwards Lifesciences

NCT01757665

ACTIVE NOT RECRUITING NA 532 participants

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Emblok

NCT05295628

ACTIVE NOT RECRUITING NA 180 participants

The JenaValve ALIGN-AR Pivotal Trial

JenaValve Technology

NCT04415047

ACTIVE NOT RECRUITING NA 25 participants

J-Valve TF Early Feasibility Study

JC Medical, Inc., an affiliate of Edwards Lifesciences

NCT06034028

COMPLETED NA 1,022 participants

Aortic Valve Replacement With Trifecta(TM)

Abbott Medical Devices

NCT00475709

COMPLETED Phase 2 300 participants

Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

Avant Immunotherapeutics

NCT00082121

COMPLETED 200 participants

Investigation of Heart Function in Patients With Heart Valve Defects

National Heart, Lung, and Blood Institute (NHLBI)

NCT00001314

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Aortic Valve Insufficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

JenaValve Trilogy Heart Valve System Device
2 trials
Trifecta Aortic Heart Valve Device
1 trials
TP10 Drug
1 trials
SENTINEL™ Cerebral Protection System Device
1 trials
EMBLOK™ Embolic Protection System ("EMBLOK EPS") Device
1 trials
Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study. Procedure
1 trials
J-Valve TF System Device
1 trials
Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M Device
1 trials

US sites by state

Facility locations filed on Aortic Valve Insufficiency trials. A trial with sites in several states counts in each.

California 9 trials
Michigan 8 trials
Illinois 8 trials
New York 7 trials
Texas 6 trials
Ohio 6 trials
Georgia 6 trials
Florida 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Aortic Valve Insufficiency page

12 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Aortic Valve Insufficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • JenaValve Technology sponsors the most Aortic Valve Insufficiency trials on record, review their full trial history before evaluating a specific study. See JenaValve Technology's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aortic Valve Insufficiency condition card totals 12 registered trials; most-linked intervention JenaValve Trilogy Heart Valve System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.